Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease

scientific article

Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1004832794
P356DOI10.1007/S13238-010-0044-8
P932PMC publication ID4875095
P698PubMed publication ID21203949

P50authorChangwen JinQ89444375
P2093author name stringFei Xue
Bin Xia
Jiaxuan Chen
Nan Zhong
Shengnan Zhang
Xiaobai Ren
Xue Kang
Zhiyong Lou
P2860cites work3D domain swapping: as domains continue to swapQ24644990
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and InhibitorsQ88519588
Design of wide-spectrum inhibitors targeting coronavirus main proteasesQ24817106
PROCHECK: a program to check the stereochemical quality of protein structuresQ26778411
Processing of X-ray diffraction data collected in oscillation modeQ26778468
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domainQ27639290
Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugsQ27641252
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitorQ27642450
Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproductionQ27643422
Domain-swapped dimerization of the HIV-1 capsid C-terminal domainQ27644067
Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulationsQ27648944
Mechanism for Controlling the Dimer-Monomer Switch and Coupling Dimerization to Catalysis of the Severe Acute Respiratory Syndrome Coronavirus 3C-Like ProteaseQ27649949
A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole estersQ27650857
Crystal structure of a stable dimer reveals the molecular basis of serpin polymerizationQ27652525
C-terminal domain of sars-CoV main protease can form a 3d domain-swapped dimerQ27654334
Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structureQ27655351
Coot: model-building tools for molecular graphicsQ27860505
1H, 13C and 15N chemical shift referencing in biomolecular NMRQ27860609
Solvent content of protein crystalsQ27860807
NMRPipe: a multidimensional spectral processing system based on UNIX pipesQ27860859
MOLMOL: a program for display and analysis of macromolecular structuresQ27860873
Phasercrystallographic softwareQ27860930
NMR View: A computer program for the visualization and analysis of NMR dataQ27860951
Refinement of macromolecular structures by the maximum-likelihood methodQ27861011
PHENIX: building new software for automated crystallographic structure determinationQ27861044
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineageQ29615331
Multivalent engagement of chromatin modifications by linked binding modulesQ29617236
A method for efficient isotopic labeling of recombinant proteinsQ29617364
Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like ProteinaseQ34270281
Proteoglycan control of cell movement during wound healing and cancer spreadingQ34438624
A novel biological actions acquired by ribonuclease through oligomerizationQ34803286
Coronavirus in severe acute respiratory syndrome (SARS).Q35203012
Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimerQ35994898
Structural insights into SARS coronavirus proteinsQ36303186
Characterization and inhibition of SARS-coronavirus main proteaseQ36447438
Drug design targeting the main protease, the Achilles' heel of coronavirusesQ36683633
Protein acrobatics in pairs--dimerization via domain swappingQ37177524
Without its N-finger, the main protease of severe acute respiratory syndrome coronavirus can form a novel dimer through its C-terminal domain.Q41780919
Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization modeQ41884048
Plasminogen activator inhibitor type 1 promotes the self-association of vitronectin into complexes exhibiting altered incorporation into the extracellular matrixQ43858114
pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analysesQ43919382
Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitorsQ44511959
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrateQ44899503
Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulationsQ45126666
Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease.Q46438629
Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.Q46747607
Correlation between dissociation and catalysis of SARS-CoV main protease.Q46753157
The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase.Q46837006
The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domainQ46944645
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.Q51660929
Enzymatic activity of the SARS coronavirus main proteinase dimer.Q53625273
A novel coronavirus and SARSQ73806367
SARS CoV main proteinase: The monomer-dimer equilibrium dissociation constantQ79403449
Only one protomer is active in the dimer of SARS 3C-like proteinaseQ82972241
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectstructural biologyQ908902
3C-like proteinase [SARS-Cov]Q89455671
SARS-CoV-1Q85438966
P304page(s)371-83
P577publication date2010-04-01
P1433published inProtein & CellQ26854012
P1476titleThree-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease
P478volume1

Reverse relations

cites work (P2860)
Q437207451H, 13C and 15N resonance assignments of SARS-CoV main protease N-terminal domain
Q37870810Activation and maturation of SARS-CoV main protease
Q30357066Atlas of coronavirus replicase structure.
Q38981574Bioinformatics and functional analyses of coronavirus nonstructural proteins involved in the formation of replicative organelles
Q35866646Critical Assessment of the Important Residues Involved in the Dimerization and Catalysis of MERS Coronavirus Main Protease
Q35131311Expression, crystallization and preliminary crystallographic study of the C-terminal half of nsp2 from SARS coronavirus
Q36236356Foldon unfolding mediates the interconversion between M(pro)-C monomer and 3D domain-swapped dimer
Q26992345From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Q30414939Functional repertoire, molecular pathways and diseases associated with 3D domain swapping in the human proteome
Q27684519Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease
Q36019255Purification, crystallization and preliminary X-ray analysis of nonstructural protein 2 (nsp2) from avian infectious bronchitis virus
Q37469524SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity.
Q39067597Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academia